Summary of: 
FOOTBALL RECOVERY STRATEGIES 
(Grégory Dupont, Mathieu Nédélec, Alan McCall, Serge Berthoin and Nicola A. Maffiuletti, 2015)

• High intensity exercise leads to fatigue.  
  
• Fatigue causes a decline in performance.  
  
• A high percentage of injuries occur late in each half of a game, suggesting that fatigue is a risk factor for injury.

• Combination of central and peripheral factors.
  
• Central fatigue = decreased maximal voluntary muscle contraction and sprinting ability.
  
• Peripheral fatigue = muscle soreness, damage, and inflammation.
  
• Depletion of glycogen stores.
  
• Dehydration.
  
• Muscle damage / stiffness / swelling.
  
• Mental fatigue / motivation.
  
• Jet lag / disrupted body clock / stress / poor sleep.

• Immediately after a match, 20M sprint time, quadriceps strength, and vertical jump height are decreased by about 10%.  
  
• Full recovery can take between two and four days.  
  
• Injury rates are increased when there are less than 6 days between matches.

"When playing two matches per week, the 3-day recovery time between two successive matches may consequently be insufficient to fully recover."

Immediately after a match, players should drink a large volume of fluid (about 150% of the sweat loss) with a high concentration of sodium (about 500 to 700 mg/L of water), flavoured milk, and tart cherry or berry juice. Then, they should eat a meal containing high-glycaemic index carbohydrate and protein within the hour following play.

Rehydration and consumption of carbohydrates and protein are effective techniques for optimising repair of muscle damage.  The addition of sodium at 500-700mg/L promotes fluid retention, stimulates thirst, delays urine production, and increases glucose absorption.  It is recommended to drink a large volume of fluid after the match instead of small quantities gradually.

It is recommended to take 1.2g of carbohydrate per kilogram of bodyweight per hour for up to 5 hours after a match to enable maximum re-synthesis of muscle glycogen stores.

20g of milk protein during the first 2 hours of post-exercise recovery stimulates muscle protein synthesis.  Flavoured milk is an effective beverage for post-exercise recovery. It contains carbohydrate and proteins in similar amounts to those used in studies demonstrating improved post-exercise recovery.

Juices such as tart cherry juice, tomato juice, or berry juice are also recommended to enhancing the recovery process. These juices are loaded with a high antioxidant capacity, which reduce oxidative stress and inflammation.

Alcohol delays recovery as it is a diuretic, increases urine output, impairs sleep, delays the muscular recovery process, and decreases maximal strength.

• Sleep is an essential part of recovery management.
  
• Lost sleep reduces endurance performance, maximal strength, cognitive performance, and the immune system.  
  
• Less than 7 hours sleep per night triples the risk of infections and double the risk of musculoskeletal injuries.
  

• Several meta-analyses confirm the benefits of cold-water immersion for recovery.
  
• The recommended regime of cold-water immersion is: whole-body immersion lasting 10 to 20 minutes at a temperature of 12 to 15°C immediately after the match.
  

• Active recovery performed after a match does not present any benefit for physical performance.
  

• Most studies fail to find a significant beneficial effect of massage for recovery.
  
• Psychological benefits: decreased subjective symptoms of soreness / improved perceptions of recovery.
  

• There is no substantial scientific evidence to support the use of stretching to enhance post-exercise recovery.
  
• Stretching is not clinically worthwhile in reducing muscle soreness in the days following exercise. 
  
• Recovery of physical performance is not improved after stretching.
  

• Meta-analysis on the effects of compression garments on recovery following damaging exercise indicated that the use of compression garments had a moderate effect on recovery of muscle strength, muscle power, creatine kinase and in reducing the severity of delayed onset muscle soreness.  
  
• A placebo effect due to wearing the garments could not be excluded.
  

1. The first step is hydration; the mass of the players should be measured and compared to the pre-match body mass in order to propose the appropriate quantity of fluid to drink (150% of body mass lost). The fluid should contain a combination of water and a large amount of sodium (500 to 700 mg/L of water).
   
2. The second step consists in drinking a tart cherry juice and chocolate milk in order to restore glycogen, to reduce oxidative stress and inflammation, to stimulate muscle repair and to promote quality and quantity of sleep.
   
3. The third step is the cold bath. The players should immerse themselves up to the neck at a temperature between 12 and 15°C for 10 to 20 minutes to accelerate the recovery process.
   
4. The fourth step is to wear a compression garment until bedtime.
   
5. The fifth step is to eat a meal high in carbohydrate with a high-glycaemic index and protein within 1 hour after the match (for example soup, well-cooked white pasta or mashed potatoes, chicken or fish, yogurts or cake).
   
6. The final step is to have a good night’s sleep.
   

WATCH DR DUPONT'S PRESENTATION AT ASPETAR'S POST-EXERCISE RECOVERY CONFERENCE:

The Shoe Aisle Dilemma

Walking into a modern running store is an exercise in sensory and cognitive overload. You are confronted by hundreds of models, each boasting proprietary foams, carbon-fiber plates, and sophisticated "stability posts." For nearly half a century, the marketing narrative has remained constant: your feet are fundamentally "broken"—characterized by arches that are too flat or movement that is too erratic—and only specific technology can prevent the inevitable injury.

However, after 50 years of footwear innovation, the needle on injury rates has not significantly moved. As a biomechanics specialist, I can tell you that many of the core beliefs held by runners and even clinicians are simply not supported by the data. The latest research indicates that our attempts to "fix" the foot have often ignored how the body actually functions. To help you navigate the wall of foam and mesh, we have distilled the most critical findings from five decades of footwear science to move you toward an evidence-based approach to the run.

1. The Pronation "Problem" is an Outdated Relic

The "Pronation Control" paradigm emerged in the late 1970s based on a logical but ultimately flawed theory: excessive inward rolling of the foot (pronation) causes internal rotation of the tibia, leading to knee injuries. This gave rise to the "motion control" shoe—stiff footwear designed to force the foot into a neutral position.

The surprising truth? Excessive pronation has not been found to be a consistent risk factor for injury. Large-scale prospective studies of novice runners demonstrate that matching a shoe to arch height—the industry standard—does not reduce injury rates. In many cases, trying to "correct" this motion can actually be more injurious than letting the foot move naturally. As the evidence suggests:

"Limited evidence exists to indicate that structural alignment is a primary risk factor for injury or that static foot posture accurately reflects dynamic foot motion during running."

The Specialist's Take: Many runners are up-sold on "stability" technology that limits their natural movement. In reality, static arch height tells us very little about dynamic joint path, and "correcting" a gait that isn't broken often creates more problems than it solves.

2. More Cushioning Does Not Guarantee Less Impact

The "Impact Force Modification" paradigm assumes that thicker midsoles act like sponges, absorbing the stress of the run. This has led to the current "maximalist" trend characterized by massive stack heights. However, the biomechanics are counter-intuitive.

Research shows that increased midsole thickness does not consistently reduce vertical Ground Reaction Force (GRF) loading rates. In fact, highly cushioned shoes can actually increase "leg stiffness" as the body adjusts its internal dampers to compensate for the unstable surface, sometimes amplifying impact loading. Furthermore, a 2020 study by Malisoux et al. revealed a "cushioning paradox": the protective effect of high cushioning appears to apply only to lighter runners; for others, the extra foam may not provide the intended injury protection.

This ties into the concept of Muscle Tuning. When your foot hits the ground, it sends soft tissue vibrations through your legs. If the shoe-surface interface is uncomfortable or overly soft, your muscles must work harder to "tune" or dampen these vibrations. This muscle activation is not only fatiguing but increases the metabolic cost of your run.

3. Your Best Lab Tool is the "Comfort Filter"

We often dismiss "comfort" as a subjective preference, but biomechanically, it is a sophisticated internal signal. The Comfort Filter paradigm suggests that a runner intuitively selects footwear that allows their joints to follow their Habitual Joint Path—the "path of least resistance" determined by their unique anatomy and tissue properties.

The data supporting this is the most striking in the field. In a landmark study of military personnel, soldiers who were allowed to select the most comfortable insole among six options saw a 53% reduction in lower-extremity injuriescompared to a control group.

"Comfort was linked to individual-specific rather than insole-specific factors."

When a shoe feels comfortable, it typically means it requires less "muscle tuning" and allows your joints to move through their preferred trajectory. Instead of relying on a salesperson's 2D video analysis to "fix" your gait, trust your feet. If a shoe feels stiff or awkward, it is likely fighting your habitual motion path and increasing your metabolic expenditure.

4. Mass is the Only Guaranteed Performance Metric

While "injury prevention" is complex and individual, "performance" is driven by a very clear variable: mass. Biomechanical science has established a direct, linear relationship between the weight of a shoe and the energy you expend.

For every 100 grams (roughly 3.5 ounces) of added mass, there is approximately a 1% increase in metabolic cost.However, the "Sweet Spot" is not found in barefoot running. Surprisingly, shod running results in 3–4% lower oxygen consumption than barefoot running. This is because a certain amount of underfoot cushioning reduces the amount of work your muscles must do to absorb shock, offsetting the metabolic penalty of the shoe's mass.

The Carbon Fiber Nuance: While "super shoes" like the Nike Vaporfly are famous for their carbon plates, the performance gain isn't just about stiffness. It is increasingly believed to be a "teeter-totter effect" driven by the shape and curvature of the plate, which favorably shifts the GRF vector anteriorly at push-off, reducing the energetic cost of propulsion.

5. The Task-Specific Recommendation

There is no "perfect shoe" for all scenarios; there is only the right tool for a specific task. To shop like an expert, move away from the "broken gait" mindset and toward strategic selection:

• For Performance: Prioritize the lowest-mass shoe that remains comfortable.
• For Recovery & Variability: Diversifying your footwear may help. Strategic use of stack height can shift loads. For example, a higher "drop" (heel-to-toe height difference) can reduce mechanical work at the ankle, which may assist during acute Achilles recovery.
• The Achilles Warning: Be cautious with long-term, exclusive use of high-resiliency foams (like those in the Vaporfly). While they reduce mechanical work at the ankle in the short term, consistent use may actually degrade Achilles tendon stiffness, potentially setting you up for future injury when you switch back to "standard" shoes.
• The General Rule: The safest evidence-based recommendation is to select a shoe that is lightweight, comfortable, and features minimal pronation control technology.

Conclusion: Listening to the Path of Least Resistance

The era of "correcting" the runner is ending. We are witnessing a paradigm shift from trying to fix a "broken" gait to facilitating a natural one. If 50 years of footwear technology hasn't lowered injury rates, it is because we have been asking the wrong questions. We should not ask what a shoe can do to our feet, but rather how a shoe can stay out of the way of our body’s natural mechanics.

The "Comfort Filter" is not just a feeling; it is a sophisticated data-processing signal that tells you a shoe aligns with your habitual joint path. Next time you are at the store, ignore the pitch about "correcting" your strike. Put the shoes on, run a few strides, and listen to the internal feedback. If the shoe feels light and like the path of least resistance, you’ve found your pair.

REF: Running Injury Paradigms and Their Influence on Footwear Design Features and Runner Assessment Methods: A Focused Review to Advance Evidence-Based Practice for Running Medicine Clinicians

For those living with "frozen shoulder"—medically known as adhesive capsulitis—the world shrinks to the radius of a locked joint. It begins with an insidious onset of deep-seated pain that gradually hardens into a debilitating "gridlock." Simple gestures become Herculean tasks: reaching for a seatbelt, pulling on a coat, or finding a sleeping position that doesn't trigger a jolt of agony. In this state of inflammation and scarring, the shoulder joint contracts, leaving patients desperate for a solution that will restore their range of motion.

To settle the debate over which intervention truly works, the UK FROST study was launched. As a multicentre, pragmatic, three-arm, superiority randomised clinical trial—the largest of its kind—it put the three most common secondary care treatments to the ultimate test. The study aimed to determine whether expensive, invasive surgery is actually superior to a structured physiotherapy pathway.

The Superiority Myth: All Roads Lead to Recovery

The most striking revelation from the UK FROST study was that at the 12-month mark, no single treatment proved "clinically superior." To measure success, researchers used the Oxford Shoulder Score (OSS), a 48-point scale where higher scores indicate better function and less pain.

The trial was designed with a "target difference" of 4 to 5 points—the minimum improvement a patient would actually notice in their daily life. While the results showed that patients who underwent Arthroscopic Capsular Release (ACR) had statistically better scores than those in the physiotherapy group (a difference of 3.06 points, p=0.011), the gap failed to reach that critical 5-point clinical threshold.

In the language of evidence-based medicine, this is a vital distinction: the surgical advantage was "statistically significant" (meaning it likely wasn't due to chance), but it wasn't "clinically significant" (meaning the patient wouldn't feel a meaningful difference between the two). As the study authors concluded: "none of the three interventions were clinically superior." Whether the patient chose the scalpel or the exercise mat, the 12-month outcome was remarkably similar.

The Cost of Invasive Action: Safety and the Surgical Scalpel

While clinical outcomes were nearly identical at one year, the journey to get there varied significantly in terms of risk. The trial evaluated three distinct pathways:

1. Early Structured Physiotherapy: A specifically designed program of 12 sessions including mobilization and home exercises, initiated by a steroid injection.
2. Manipulation Under Anaesthesia (MUA): A procedure where a surgeon stretches and tears the scarred capsule while the patient is unconscious, followed by a steroid injection and postprocedural physiotherapy.
3. Arthroscopic Capsular Release (ACR): A more invasive surgery to divide the contracted capsule, often followed by manipulation and always by postprocedural physiotherapy.

The safety data was telling. ACR carried the highest risk profile, with eight serious adverse events reported, including one patient suffering a stroke and others experiencing deep vein thrombosis or surgical site infections. In contrast, MUA saw only two serious events, and the early structured physiotherapy group saw zero. This suggests that while ACR is a powerful tool, its higher complication rate makes it a "selective" option rather than a default first-line treatment.

The Waiting Game: Why Access is Therapy

For a patient whose life is on hold, the most important metric isn't just how they recover, but how fast they can start. The UK FROST study revealed a massive disparity in access. The median wait time for physiotherapy was just 14 days. For MUA, it was 57 days, and for ACR, it stretched to 72 days.

This delay has real-world consequences. At the 3-month follow-up, the ACR group actually reported worse outcomes than the other two groups. This "surgical lag" occurred because many ACR patients were either still on the waiting list or were in the early, painful stages of post-operative recovery while the physiotherapy group had already completed their treatment. When you are unable to sleep or work, a two-month head start on recovery is a significant clinical advantage.

Efficiency in the Theatre: The Economic Winner

From a healthcare system perspective, the UK FROST study provides a clear economic winner: Manipulation Under Anaesthesia (MUA). The researchers used Quality-Adjusted Life-Years (QALYs)—a metric where one unit represents one year of perfect health—to determine value for money.

At the standard NHS threshold of £20,000 per QALY, MUA had an 86% probability of being the most cost-effective treatment. ACR, by comparison, was substantially more expensive—costing roughly £1,733 more per patient than physiotherapy—without providing a commensurate leap in health quality. In a system where hospital beds and operating theatre time are precious resources, MUA offers the most efficient balance of cost and clinical improvement.

The Reality of Persistence

There is a final, sobering takeaway for both clinicians and patients. While the treatments in this trial were highly successful—most participants reached nearly full function with a median score of 43 out of 48—frozen shoulder remains a stubborn adversary.

Historical data on the general population suggests that around 40% of patients may still report some persistent symptoms even four years after the initial onset. While the UK FROST participants generally fared better, the "slow or incomplete" nature of recovery in the broader population serves as a reminder that this condition is a marathon, not a sprint.

There is, however, a notable trade-off regarding further intervention. While the physiotherapy pathway is safer and faster to access, 15% of those patients eventually required further treatment (such as surgery) compared to only 4% of those who started with ACR.

A Blueprint for Future Shoulder Care

The UK FROST study has effectively redrawn the map for adhesive capsulitis treatment. It proves that more invasive does not necessarily mean better.

For the patient in the consultation room, the "Early Structured Physiotherapy" pathway—the combination of a steroid injection followed by expert-led exercise—should be a primary consideration. It is fast, safe, and at 12 months, delivers results that are nearly indistinguishable from surgery. MUA stands as the most cost-effective hospital intervention, while ACR is best reserved for complex cases or when less invasive methods have failed.

Ultimately, the study empowers the patient. If the long-term outcomes are virtually the same, would you choose the surgical theater and the risks that come with it, or would you choose the injection and the exercise mat? The evidence suggests that for most, the less invasive path is just as effective.

​REF: ​

• Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial​